Lipoprotein lipase (LPL) is an adipocyte enzyme that hydrolyzes the triglyceride core of chylomicrons and VLDL, and human fat obtains essentially all its lipid through the action of LPL. Since weight loss leads to an increase in adipocyte LPL expression, LPL contributes to weight loss recidivism by increasingly """"""""stuffing"""""""" fat cells. LPL also clears triglyceride-rich lipoproteins from plasma, and therefore is important in the prevention of atherosclerosis. Recent studies, by us and others, indicated that LPL regulation is complex; under certain circumstances LPL regulation occurs transcriptionally, yet under other conditions occurs post- transcriptionally. We recently identified a novel mechanism of LPL regulation which occurs at the level of translation. Thus, these studies will investigate the mechanisms of LPL translational regulation in adipocytes from rats and humans.
The specific aims are as follows: 1. Determine the mechanism of translational regulation of LPL. These studies will first determine whether LPL translational regulation occurs due to post-transcriptional changes in LPL mRNA structure. Subsequently, we will determine whether LPL translational regulation occurs at the level of initiation or elongation, and search for a trans-acting RNA binding protein. Using LPL mRNA constructs deficient or defective in the 5' or 3' untranslated region (UTR), we will determine what structural features of the LPL mRNA are essential for regulation of translation. These constructs will be tested by an in vitro assay for translation regulation, as well as by in vivo analysis of expression, after transfection into 3T3-L1 cells. We will use these approaches to study the mechanism of translational regulation by thyroid hormone, catecholamines, and glucose. 2. Post-translational regulation of LPL. We have already completed most of this specific aim, which examined the role of post-translational oligosaccharide processing on LPL catalytic activity, secretion, and degradation. 3. Characterization of the role of translation in LPL physiologic regulation in humans. Our recent studies have observed translational regulation of LPL when diabetics are treated with either insulin or sulfonylurea drugs. To examine the mechanism of translational regulation of LPL in humans, we will use the approaches described above to study LPL expression in diabetics both before and after improved control. These studies will provide significant information on a novel mechanism of regulation of LPL, which is central to an understanding of the metabolic defects of obesity and atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK039176-04A3
Application #
3238903
Study Section
Metabolism Study Section (MET)
Project Start
1988-09-01
Project End
1997-01-30
Budget Start
1993-02-01
Budget End
1994-01-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Ye, Ruisong; Pi, Min; Cox, John V et al. (2017) CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model. J Exp Clin Cancer Res 36:90
Walton, R Grace; Zhu, Beibei; Unal, Resat et al. (2015) Increasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesity. J Biol Chem 290:11547-56
Zhang, Haihong; Xie, Chenghui; Spencer, Horace J et al. (2011) Obesity and hepatosteatosis in mice with enhanced oxidative DNA damage processing in mitochondria. Am J Pathol 178:1715-27
Yao-Borengasser, Aiwei; Varma, Vijayalakshmi; Coker, Robert H et al. (2011) Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone. Metabolism 60:1012-20
Unal, Resat; Yao-Borengasser, Aiwei; Varma, Vijayalakshmi et al. (2010) Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J Clin Endocrinol Metab 95:2993-3001
Spencer, Michael; Yao-Borengasser, Aiwei; Unal, Resat et al. (2010) Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab 299:E1016-27
Rasouli, Neda; Yao-Borengasser, Aiwei; Varma, Vijayalakshmi et al. (2009) Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol 29:1328-35
Varma, Vijayalakshmi; Yao-Borengasser, Aiwei; Rasouli, Neda et al. (2009) Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296:E1300-10
Banga, Anannya; Unal, Resat; Tripathi, Preeti et al. (2009) Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 296:E480-9
Unal, Resat; Pokrovskaya, Irina; Tripathi, Preeti et al. (2008) Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Calpha activates binding of the C subunit of protein kinase A to the 3'-untranslated region of the lipoprotein lipase mRNA. Biochem J 413:315-22

Showing the most recent 10 out of 11 publications